[3P-0564] Effect of HDAC Inhibitor MS-275 on Vascular Permeability and Activity of Cancer Immunostimulants

^○Mayumi Kinoshita¹, Taito Kashio¹, Keisuke Shirakura¹, Kousuke Muraoka¹, Shohei Koyama^{2, 3}, Yasuo Yoshioka^{1, 4, 5, 6, 7}, Ryo Suzuki^{8, 9}, Taiki Aoshi⁴, Yasushi Fujio¹, Takefumi Doi¹, Yoshiaki Okada¹ (1.Grad. Sch. Pharm. Sci., Osaka University, 2.Grad. Sch. Med., Osaka University, 3.NCC-EPOC, 4.RIMD, Osaka University, 5.OTRI, Osaka University, 6.BIKEN Foundation, Osaka University, 7.MEI, Osaka University, 8.Fac. Pharm-Sci., Teikyo University, 9.ACRO, Teikyo University)

j . Cancer Tissue / Cancer Therapeutics(4 . Animal and Plant Physiology, and Diseases)